Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review

Agarwal D, Marques G, de la Torre-Díez I, Franco Martin MA, García Zapiraín B, Martín Rodríguez F.

Sensors (Basel). 2021 Oct 31;21(21):7259. doi: 10.3390/s21217259.

Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

Pajewski NM, Elahi FM, Tamura MK, Hinman JD, Nasrallah IM, Ix JH, Miller LM, Launer LJ, Wright CB, Supiano MA, Lerner AJ, Sudduth TL, Killeen AA, Cheung AK, Reboussin DM, Wilcock DM, Williamson JD.

Alzheimers Dement. 2022 Aug;18(8):1472-1483. doi: 10.1002/alz.12496. Epub 2021 Nov 17.

Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers

Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM.

Biosens Bioelectron. 2022 Feb 1;197:113789. doi: 10.1016/j.bios.2021.113789. Epub 2021 Nov 14.

Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis

Anita NZ, Zebarth J, Chan B, Wu CY, Syed T, Shahrul D, Nguyen MM, Pakosh M, Herrmann N, Lanctôt KL, Swardfager W.

Brain Behav Immun. 2022 Feb;100:55-69. doi: 10.1016/j.bbi.2021.11.005. Epub 2021 Nov 20.

A potential biomarker of preclinical Alzheimer's disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments

Yan Y, Aierken A, Wang C, Song D, Ni J, Wang Z, Quan Z, Qing H.

Neurosci Biobehav Rev. 2022 Jan;132:857-869. doi: 10.1016/j.neubiorev.2021.11.009. Epub 2021 Nov 20.

Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration

Gijs M, Ramakers IHGB, Visser PJ, Verhey FRJ, van de Waarenburg MPH, Schalkwijk CG, Nuijts RMMA, Webers CAB.

Sci Rep. 2021 Nov 22;11(1):22675. doi: 10.1038/s41598-021-01993-x.

Iron Homeostasis Disorder and Alzheimer's Disease

Peng Y, Chang X, Lang M.

Int J Mol Sci. 2021 Nov 18;22(22):12442. doi: 10.3390/ijms222212442.

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M.

Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.

[Depression and its relationship with mild cognitive impairment and Alzheimer disease: A review study]

González Hernández A, Rodríguez Quintero AM, Bonilla Santos J.

Rev Esp Geriatr Gerontol. 2022 Mar-Apr;57(2):118-128. doi: 10.1016/j.regg.2021.10.002. Epub 2021 Nov 27.

Blood-based biomarkers for Alzheimer's disease

Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O.

EMBO Mol Med. 2022 Jan 11;14(1):e14408. doi: 10.15252/emmm.202114408. Epub 2021 Dec 3.

Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects

Tumati S, Herrmann N, Marotta G, Li A, Lanctôt KL.

Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence

Gleason CE, Zuelsdorff M, Gooding DC, Kind AJH, Johnson AL, James TT, Lambrou NH, Wyman MF, Ketchum FB, Gee A, Johnson SC, Bendlin BB, Zetterberg H.

Alzheimers Dement. 2022 Aug;18(8):1545-1564. doi: 10.1002/alz.12511. Epub 2021 Dec 6.

The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment

Stites SD, Gill J, Largent EA, Harkins K, Sankar P, Krieger A, Karlawish J.

Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective

Ricci M, Cimini A, Camedda R, Chiaravalloti A, Schillaci O.

Int J Mol Sci. 2021 Nov 30;22(23):13002. doi: 10.3390/ijms222313002.

miRNAs as Therapeutic Tools in Alzheimer's Disease

Lee CY, Ryu IS, Ryu JH, Cho HJ.

Int J Mol Sci. 2021 Dec 1;22(23):13012. doi: 10.3390/ijms222313012.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias